• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings

    4/22/24 2:46:36 PM ET
    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Blank Checks
    Finance
    Get the next $HEPA alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on Monday.

    The Dow traded up 1.02% to 38,373.22 while the NASDAQ rose 1.45% to 15,503.89. The S&P 500 also rose, gaining, 1.22% to 5,027.92.

    Check This Out: Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

    Leading and Lagging Sectors

    Financial shares climbed by 1.3% on Monday.

    In trading on Monday, materials shares rose by just 0.2%.

    Top Headline

    Shares of Zions Bancorporation, N.A. (NASDAQ:ZION) gained around 4% on Monday after the company reported upbeat earnings for its first quarter.

    The company posted a first-quarter FY24 revenue decline of 11.6% year-on-year to $742 million, missing the analyst consensus estimate of $743.481 million. Adjusted EPS of $1.03 beat the analyst consensus estimate of 98 cents.

    Equities Trading UP
                           

    • Moolec Science SA (NASDAQ:MLEC) shares shot up 63% to $2.26 after the company announced that it received USDA approval for plant-grown animal proteins.
    • Shares of NewGenIvf Group Limited (NASDAQ:NIVF) got a boost, surging 113% to $1.56 after the company signed a non-binding term sheet for a potential reverse merger with European Wellness Investment Holdings.
    • Matterport, Inc. (NASDAQ:MTTR) shares were also up, gaining 179% to $4.8550 after the company announced a deal to be acquired by online real estate marketplace provider CoStar Group.

    Equities Trading DOWN

    • Vaxxinity, Inc. (NASDAQ:VAXX) shares dropped 46% to $0.2569 after the company announced its intention to voluntarily delist and deregister its Class A common stock.
    • Shares of Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) were down 28% to $1.51 after the company announced that it began wind-down activities in its Phase 2b “ASCEND-NASH Trial.
    • Warrantee Inc. (NASDAQ:WRNT) was down, falling 34% to $0.2798 after the company announced a receipt of a Nasdaq delisting determination and a plan to appeal.

    Also Check This Out: This Analyst With 85% Accuracy Rate Sees More Than 37% Upside In AMD – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

    Commodities

    In commodity news, oil traded up 0.3% to $83.40 while gold traded down 2.9% at $2,343.90.

    Silver traded down 5.7% to $27.21 on Monday, while copper fell 0.4% to $4.48.

    Euro zone

    European shares were mostly higher today. The eurozone's STOXX 600 rose 0.60%, London's FTSE 100 rose 1.62% while Spain's IBEX 35 Index climbed 1.50% The German DAX gained 0.70% French CAC 40 rose 0.38% while Italy's FTSE MIB Index fell 0.58%.

    Eurozone's government deficit to GDP ratio fell to 3.6% in 2023 compared to a revised 3.7% in the prior year.

    Asia Pacific Markets

    Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 1%, Hong Kong's Hang Seng Index gaining 1.77%, China's Shanghai Composite falling 0.67% and India's S&P BSE Sensex gaining 0.77%.

    The People’s Bank of China maintained its key lending rates at the April fixing.

    Economics

    The Chicago Fed National Activity Index increased to +0.15 in March versus a revised reading of +0.09 in the previous month, topping market estimates of +0.09.

    Now Read This: Progressive, Q2 Holdings And 2 Other Stocks Insiders Are Selling

    Get the next $HEPA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HEPA
    $MLEC
    $MTTR
    $VAXX

    CompanyDatePrice TargetRatingAnalyst
    Zions Bancorporation N.A.
    $ZION
    3/9/2026$65.00Neutral → Outperform
    Robert W. Baird
    Zions Bancorporation N.A.
    $ZION
    3/2/2026$75.00Equal-Weight → Overweight
    Morgan Stanley
    Zions Bancorporation N.A.
    $ZION
    2/9/2026$65.00Outperform → Neutral
    Robert W. Baird
    Zions Bancorporation N.A.
    $ZION
    11/19/2025$60.00Hold → Buy
    Jefferies
    Zions Bancorporation N.A.
    $ZION
    10/23/2025$62.00Underperform → Neutral
    BofA Securities
    Zions Bancorporation N.A.
    $ZION
    10/17/2025$65.00Neutral → Outperform
    Robert W. Baird
    Zions Bancorporation N.A.
    $ZION
    9/25/2025$64.00Hold
    TD Cowen
    Zions Bancorporation N.A.
    $ZION
    9/10/2025$64.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President Stephens Steven Dan covered exercise/tax liability with 95 shares, decreasing direct ownership by 0.20% to 48,105 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    3/9/26 4:41:01 PM ET
    $ZION
    Major Banks
    Finance

    Executive Vice President Stephens Steven Dan covered exercise/tax liability with 84 shares, decreasing direct ownership by 0.17% to 48,200 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/27/26 4:36:49 PM ET
    $ZION
    Major Banks
    Finance

    Chairman & CEO Simmons Harris H bought $265,635 worth of shares (4,500 units at $59.03), increasing direct ownership by 0.34% to 1,317,493 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/25/26 4:33:19 PM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    SEC Filings

    View All

    Hepion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Hepion Pharmaceuticals, Inc. (0001583771) (Filer)

    3/3/26 8:11:27 AM ET
    $HEPA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Moolec Science SA

    6-K - Moolec Science SA (0001937737) (Filer)

    2/26/26 4:01:13 PM ET
    $MLEC
    Blank Checks
    Finance

    SEC Form 10-K filed by Zions Bancorporation N.A.

    10-K - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Filer)

    2/24/26 3:25:24 PM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Zions Bancorp upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Zions Bancorp from Neutral to Outperform and set a new price target of $65.00

    3/9/26 8:45:59 AM ET
    $ZION
    Major Banks
    Finance

    Zions Bancorp upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Zions Bancorp from Equal-Weight to Overweight and set a new price target of $75.00

    3/2/26 8:30:25 AM ET
    $ZION
    Major Banks
    Finance

    Zions Bancorp downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Zions Bancorp from Outperform to Neutral and set a new price target of $65.00

    2/9/26 7:00:44 AM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Simmons Harris H bought $265,635 worth of shares (4,500 units at $59.03), increasing direct ownership by 0.34% to 1,317,493 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/25/26 4:33:19 PM ET
    $ZION
    Major Banks
    Finance

    Simmons Harris H bought $154,160 worth of shares (4,000 units at $38.54), increasing direct ownership by 0.31% to 1,312,987 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/28/24 5:18:13 PM ET
    $ZION
    Major Banks
    Finance

    Simmons Harris H bought $140,350 worth of shares (3,600 units at $38.99), increasing direct ownership by 0.29% to 1,261,866 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/7/24 5:16:54 PM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Leadership Changes Announced at Zions Bancorporation's Technology and Operations

    SALT LAKE CITY, March 3, 2026 /PRNewswire/ -- Zions Bancorporation (NASDAQ:ZION) today announced leadership changes in its technology and operations team, which are effective immediately: Jennifer Smith, who has served as Chief Technology and Operations Officer since 2015, will leave the bank following a 20-year career with Zions.Zions' Enterprise Technology and Operations ("ETO") will be led by a partnership of Margaret Mayer as Chief Information Officer and Ken Collins as Chief Transformation and Operations Officer. Margaret joined Zions two years ago as Chief Technology Offic

    3/3/26 4:00:00 PM ET
    $ZION
    Major Banks
    Finance

    Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma

    Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion's strategic shift to advancing clinically proven liquid biopsy tests under new leadership MORRISTOWN, N.J., March 03, 2026 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from Cirna Diagnostics LLC, a novel biomarker assay that detects mutant circulating tumor RNA (ctRNA) to facilitate early diagnosis of hepatocellular carcinoma (HCC) in high-risk patients (cirrhosis). Most cases of liver cancer (75-90%) are HCC, and HCC is the sixth most common cancer w

    3/3/26 7:35:00 AM ET
    $HEPA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZIONS BANCORPORATION TO PRESENT AT THE RBC CAPITAL MARKETS 2026 GLOBAL FINANCIAL INSTITUTIONS CONFERENCE

    SALT LAKE CITY, Feb. 24, 2026 /PRNewswire/ -- Scott McLean, President and COO of Zions Bancorporation, N.A. (NASDAQ:ZION), will make a presentation at the RBC Capital Markets Global Financial Institutions Conference on Tuesday, March 10th at 11:20 am Eastern.  An audio webcast of the session may be accessed on the Zions Bancorporation website, zionsbancorporation.com.  A replay of the presentation will also be made available following the event for one year. Zions Bancorporation, N.A. is one of the nation's premier financial services companies with approximately $89 billion of t

    2/24/26 2:04:00 PM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Leadership Updates

    Live Leadership Updates

    View All

    Vectra Bank Colorado welcomes Dominic Karaba as its next President & CEO

    Vectra Bank Welcomes New Local Leadership DENVER, Nov. 10, 2025 /PRNewswire/ -- Vectra Bank Colorado is proud to announce the appointment of Dominic Karaba as its next President and CEO. Karaba succeeds Bruce Alexander, who will retire after a 25-year career at Vectra Bank. This transition marks an exciting chapter for Vectra Bank, as Vectra continues its commitment to local leadership, community engagement, and pro-active relationship banking. Karaba brings a wealth of experience to Vectra Bank, having served in senior executive roles in Commercial and Business banking in Col

    11/10/25 2:43:00 PM ET
    $ZION
    Major Banks
    Finance

    Vectra Bank Colorado Announces Retirement of CEO Bruce Alexander

    DENVER, April 29, 2025 /PRNewswire/ -- Vectra Bank Colorado today announced the retirement of President and CEO, Bruce Alexander. Bruce's 25-year tenure at Vectra Bank has been marked by significant achievements, exceptional growth, and an unwavering commitment to Colorado, the bank, its employees, shareholders, and the communities it serves. Bruce Alexander joined Vectra Bank in 2000, following the merger of 21 community banks acquired by Zions Bancorporation. Under Bruce's leadership, Vectra Bank grew from $1 billion in assets to an impressive $4 billion. His vision and stra

    4/29/25 11:50:00 AM ET
    $ZION
    Major Banks
    Finance

    CALIFORNIA BANK & TRUST EXPANDS PRESENCE IN THE COACHELLA VALLEY FOLLOWING ACQUISITION OF FIRSTBANK'S CALIFORNIA OPERATIONS

    The community is invited to celebrate at Grand Opening event on March 24 SAN DIEGO, March 24, 2025 /PRNewswire/ -- California Bank & Trust (CB&T), a leading financial institution serving businesses and individuals across the state, is strengthening its presence in the Coachella Valley following the successful acquisition of FirstBank's California banking operations. The integration of four newly converted branches in the Coachella Valley reinforces CB&T's long-standing commitment to providing comprehensive banking solutions to local businesses, families and community organizations.

    3/24/25 9:00:00 AM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Financials

    Live finance-specific insights

    View All

    ZIONS BANCORPORATION'S BOARD ANNOUNCES APPROVAL OF SHARE REPURCHASE AND DECLARES DIVIDENDS ON COMMON AND PREFERRED STOCK

    SALT LAKE CITY, Jan. 30, 2026 /PRNewswire/ -- Zions Bancorporation, N.A. (NASDAQ:ZION) announced today that its board of directors ("board") has authorized a share repurchase of up to $75 million of the company's common stock for the first quarter of 2026. The timing and amount of any such action will depend on market conditions, regulatory requirements, and other factors or uncertainties and may be updated at the discretion of the board. The board also declared a regular quarterly dividend of $0.45 per common share, payable February 19, 2026, to shareholders of record at the

    1/30/26 2:01:00 PM ET
    $ZION
    Major Banks
    Finance

    Zions Bancorporation, National Association Reports Fourth Quarter Financial Results

    SALT LAKE CITY, Jan. 20, 2026 /PRNewswire/ -- Zions Bancorporation, N.A. (NASDAQ:ZION) ("Zions" or "the Bank") today reported net earnings applicable to common shareholders for the fourth quarter of 2025 of $262 million, or $1.76 per diluted common share, compared with net earnings applicable to common shareholders of $200 million, or $1.34 per diluted common share, for the fourth quarter of 2024, and net earnings applicable to common shareholders of $221 million, or $1.48 per diluted common share, for the third quarter of 2025. Harris H. Simmons, Chairman and CEO of Zions Ban

    1/20/26 4:10:00 PM ET
    $ZION
    Major Banks
    Finance

    ZIONS BANCORPORATION ANNOUNCES 2026 EARNINGS RELEASE DATES

    SALT LAKE CITY, Dec. 3, 2025 /PRNewswire/ -- Zions Bancorporation, N.A. (NASDAQ:ZION) announced its expected earnings release dates for the fiscal fourth quarter of 2025 and the first, second, and third quarters of 2026. Zions expects to report its financial results on the following dates and times: For the fiscal period                   Earnings Release Conference Call Date and Time Fourth Quarter 2025                Jan. 20, 2026, at 5:30 p.m. ET (3:30 p.m. MT) First Quarter 2026                  April 20, 2026, at 5:30 p.m. ET (3:30 p.m. MT) Second Quarter 2026           

    12/3/25 4:30:00 PM ET
    $ZION
    Major Banks
    Finance

    $HEPA
    $MLEC
    $MTTR
    $VAXX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hepion Pharmaceuticals Inc.

    SC 13G/A - Hepion Pharmaceuticals, Inc. (0001583771) (Subject)

    11/14/24 4:07:59 PM ET
    $HEPA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Zions Bancorporation N.A.

    SC 13G/A - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Subject)

    10/18/24 12:53:37 PM ET
    $ZION
    Major Banks
    Finance

    SEC Form SC 13D filed by Moolec Science SA

    SC 13D - Moolec Science SA (0001937737) (Subject)

    4/17/24 5:14:28 PM ET
    $MLEC
    Blank Checks
    Finance